PE20080712A1 - TREATMENT OF CYYSTIC FIBROSIS WITH ANTIBIOTICS BY SUPPLYING A WHIRLPOOL - Google Patents

TREATMENT OF CYYSTIC FIBROSIS WITH ANTIBIOTICS BY SUPPLYING A WHIRLPOOL

Info

Publication number
PE20080712A1
PE20080712A1 PE2007000681A PE2007000681A PE20080712A1 PE 20080712 A1 PE20080712 A1 PE 20080712A1 PE 2007000681 A PE2007000681 A PE 2007000681A PE 2007000681 A PE2007000681 A PE 2007000681A PE 20080712 A1 PE20080712 A1 PE 20080712A1
Authority
PE
Peru
Prior art keywords
treatment
dextrose
injection
fibrosis
cyystic
Prior art date
Application number
PE2007000681A
Other languages
Spanish (es)
Inventor
Hanumantharao Tatapudy
Syed M Shad
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38657254&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080712(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20080712A1 publication Critical patent/PE20080712A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Abstract

SE REFIERE A UNA COMPOSICION EN AEROSOL LIQUIDA QUE COMPRENDE UNA DROGA ANTIBIOTICA TAL COMO ZOSYN(PIPERACICLINA Y TAZOBACTAM), PIPERACILINA, TAZOBACTAM O TYGACIL (TIGLECICLINA); Y UN DILUYENTE QUE COMPRENDE AGUA ESTERIL PARA INYECCION, 0.9% DE CLORURO DE SODIO PARA INYECCION, 5% DE DEXTROSA PARA INYECCION; 5% DE DEXTROSA, 5% DE DEXTROSA, ENTRE OTROS, EL CUAL SE COLOCA EN EL DEPOSITO DEL SISTEMA DE SUMINISTRO DE DROGA EN AEROSOL SWIRLER, QUE SE CONECTA A UNA FUENTE DE GAS PRESURIZADA, EN DONDE EL TAMANO DE LAS PARTICULAS OBTENIDAS ES DE AL MENOS 90% DE LAS GOTAS DE 1 A 3 MICRONES O MENOS. DICHA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE ENFERMEDADES RESPIRATORIAS TAL COMO LA FIBROSIS CISTICAREFERS TO A LIQUID AEROSOL COMPOSITION INCLUDING AN ANTIBIOTIC DRUG SUCH AS ZOSYN (PIPERACICLINA AND TAZOBACTAM), PIPERACILINA, TAZOBACTAM OR TYGACIL (TIGLECICLINA); AND A THINNER THAT INCLUDES STERILE WATER FOR INJECTION, 0.9% SODIUM CHLORIDE FOR INJECTION, 5% DEXTROSE FOR INJECTION; 5% DEXTROSE, 5% DEXTROSE, AMONG OTHERS, WHICH IS PLACED IN THE TANK OF THE SWIRLER DRUG SUPPLY SYSTEM IN AEROSOL, WHICH IS CONNECTED TO A PRESSURIZED GAS SOURCE, WHERE THE SIZE OF THE PARTICLES OBTAINED IS AT LEAST 90% OF DROPS OF 1 TO 3 MICRONS OR LESS. SUCH COMPOSITION IS USEFUL FOR THE TREATMENT OF RESPIRATORY DISEASES SUCH AS CYSTIC FIBROSIS

PE2007000681A 2006-06-07 2007-06-01 TREATMENT OF CYYSTIC FIBROSIS WITH ANTIBIOTICS BY SUPPLYING A WHIRLPOOL PE20080712A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81167106P 2006-06-07 2006-06-07

Publications (1)

Publication Number Publication Date
PE20080712A1 true PE20080712A1 (en) 2008-05-22

Family

ID=38657254

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000681A PE20080712A1 (en) 2006-06-07 2007-06-01 TREATMENT OF CYYSTIC FIBROSIS WITH ANTIBIOTICS BY SUPPLYING A WHIRLPOOL

Country Status (4)

Country Link
AR (1) AR061263A1 (en)
PE (1) PE20080712A1 (en)
TW (1) TW200815003A (en)
WO (1) WO2007145866A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102641249A (en) * 2012-05-06 2012-08-22 江苏奥赛康药业股份有限公司 Preparation method of tigecycline composition
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
AU2014227660B2 (en) 2013-03-15 2014-11-06 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions
ES2800603T3 (en) 2013-09-09 2021-01-04 Merck Sharp & Dohme Treatment of infections with ceftolozane / tazobactam in patients with renal impairment
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
US9566399B1 (en) 2015-04-14 2017-02-14 Clempharma LLC Deep lung alveolar aerosol targeted drug delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5611332A (en) * 1995-03-22 1997-03-18 Bono; Michael Aerosol inhalation device containing a rain-off chamber
US20040009126A1 (en) * 2002-03-05 2004-01-15 Transave, Inc. Inhalation system for prevention and treatment of intracellular infections

Also Published As

Publication number Publication date
WO2007145866A1 (en) 2007-12-21
AR061263A1 (en) 2008-08-13
TW200815003A (en) 2008-04-01

Similar Documents

Publication Publication Date Title
PE20080712A1 (en) TREATMENT OF CYYSTIC FIBROSIS WITH ANTIBIOTICS BY SUPPLYING A WHIRLPOOL
PE20130589A1 (en) COMPOSITIONS AND METHODS FOR SUPPLYING THE CENTRAL NERVOUS SYSTEM OF ARYLSULFATASE A
PE20061015A1 (en) PHARMACEUTICAL FORMS WITH IMPROVED PHARMACOKINETIC PROPERTIES
AR064078A1 (en) SYSTEM OF ADMINISTRATION OF BIOCOMPATIBLE INJECTABLE INTRAOCULAR PHARMACOS, ITS USE TO PREPARE A MEDICINAL PRODUCT AND PROCESS FOR PREPARATION
BRPI0707845B8 (en) drug delivery positive
PE20131324A1 (en) SUBCUTANEOUS FORMULATION OF ANTI-HER2 ANTIBODY
PE20110302A1 (en) PHARMACEUTICAL FORMULATION OF AN ANTIBODY AGAINST P-SELECTIN
AR062059A1 (en) PHARMACEUTICAL FOAM WITH FATTY ACID
PE20120777A1 (en) COMBINATION OF A NUCLEOSIDE POLYMERASE INHIBITOR WITH A MACROCYCLIC PROTEASE INHIBITOR AND ITS USE IN THE TREATMENT OF HEPATITIS C, HEPATIC FIBROSIS AND ALTERED HEPATIC FUNCTION
MX9301823A (en) COMPOSITION FOR THE SUPPLY OF CONTROLLED RELEASE OF A BIOLOGICALLY ACTIVE AGENT.
BRPI0603087A (en) needle free jet injection drug delivery device
BR112014012522A2 (en) method for filling a reservoir, reservoir and assembly for filling a reservoir
AR087210A2 (en) PHARMACEUTICAL FORMULATION OF THE SODIUM SALT OF TELMISARTAN
AR070025A1 (en) USE OF DERIVATIVES OF 1-AMINO-ALQUILCICLOHEXANO FOR THE TREATMENT OF COCLEAR TINNITUS AND PHARMACEUTICAL COMPOSITION
NZ603345A (en) Stabilized ophthalmic galactomannan formulations
PE20141539A1 (en) A NEW THERAPEUTIC COMPOSITION CONTAINING APOMORPHINE AS AN ACTIVE PRINCIPLE
PE20110711A1 (en) TREATMENT OF COGNITIVE DISORDERS WITH (R) -7-CHLORO-N- (QUINUCLIDIN-3-IL) BENZO [B] THIOPHENE-2-CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
PE20080329A1 (en) TREATMENT OF CYST FIBROSIS WITH ANTIBIOTICS VIA A DRUG IN AEROSOL
MX2010004373A (en) Non-aqueous water-miscible materials as vehicles for drug delivery.
ATE507818T1 (en) ORAL ADMINISTRATION OF A CALCITONIN
AR114324A1 (en) MODIFIED LIPIDED RELAXIN B-CHAIN PEPTIDES AND THEIR THERAPEUTIC USE
BR112013027010A2 (en) method of producing substances with supersaturated gas, device for their transdermal delivery, and their uses
AR014176A1 (en) PHARMACEUTICAL COMPOSITIONS OF URIDINE TRYPHOSPHATE.
AR114323A1 (en) MODIFIED RELAXIN B-CHAIN PEPTIDES AND THEIR THERAPEUTIC USE
ATE539761T1 (en) AGENT FOR INJECTION PURPOSES CONTAINING AN ANTIBIOTIC AND SOLUTION FOR INJECTION CONTAINING THE AGENT

Legal Events

Date Code Title Description
FA Abandonment or withdrawal